Intelligent Breast Cancer Diagnosis System using Synergistic Combinations of DOT, AI, IoT, and Blockchain

Publication ID: 24-11857289_0003_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Breast Cancer Diagnosis System using Synergistic Combinations of DOT, AI, IoT, and Blockchain,” Published Technical Disclosure No. 24-11857289_0003_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857289_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,289.

Summary of the Inventive Concept

A novel system integrating diffuse optical tomography (DOT) with AI, IoT, and blockchain technologies to provide accurate and personalized breast cancer diagnosis, risk assessment, and monitoring.

Background and Problem Solved

The original patent disclosed systems and methods for optimizing functional images of a lesion region using guided diffuse optical tomography. However, the existing technology has limitations in terms of accuracy, data security, and personalized diagnosis. The new inventive concept addresses these limitations by synergistically combining DOT with AI, IoT, and blockchain technologies to provide a more comprehensive and accurate breast cancer diagnosis system.

Detailed Description of the Inventive Concept

The system comprises a DOT device, an AI-powered processor, an IoT-enabled data transmission module, and a blockchain-based data storage system. The DOT device acquires lesion functional data and reference functional data from a healthy tissue region. The AI-powered processor analyzes the data using machine learning algorithms to detect vasculature distribution and assess tumor malignancy. The IoT-enabled module transmits the data to a cloud-based analytics platform, and the blockchain-based system securely stores the data. The system can be used for personalized breast cancer risk assessment, monitoring, and diagnosis. The AI-powered analytics engine can also detect anomalies indicative of breast cancer and generate a report.

Novelty and Inventive Step

The new inventive concept is novel and non-obvious in its synergistic combination of DOT, AI, IoT, and blockchain technologies to provide a more accurate and personalized breast cancer diagnosis system. The use of AI-powered processors, IoT-enabled data transmission, and blockchain-based data storage provides a unique and innovative approach to breast cancer diagnosis and monitoring.

Alternative Embodiments and Variations

Alternative embodiments of the system could include the use of different AI algorithms, IoT protocols, or blockchain architectures. The system could also be adapted for use in other medical imaging applications, such as detecting cardiovascular disease or monitoring diabetes.

Potential Commercial Applications and Market

The intelligent breast cancer diagnosis system has significant commercial potential in the medical imaging and healthcare industries. The system could be marketed to hospitals, clinics, and medical research institutions, and could also be used in personalized medicine and preventive care applications.

Field of Art

Medical imaging technologies, specifically diffuse optical tomography (DOT) for breast cancer diagnostics, requiring advanced signal processing, machine learning, and medical imaging expertise

Person of Ordinary Skill (PHOSITA) Profile

A professional with a PhD or MS in biomedical engineering, expertise in medical imaging, signal processing algorithms, machine learning techniques, and knowledge of medical diagnostic technologies

Obviousness Rationale

A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies with existing DOT imaging techniques represents a predictable technological evolution. The core DOT imaging methodology remains consistent with the source patent, while the additional technologies provide incremental improvements in data analysis, transmission, and storage. The combination of known technologies to achieve enhanced diagnostic capabilities would be considered an obvious extension of existing medical imaging approaches.

Obvious Combinations & Variations

Source Patent Element
DOT device for acquiring lesion functional data and reference functional data from breast tissue
PTD Variation
Adding AI-powered processing to analyze vasculature distribution and tumor malignancy
Obviousness Reasoning
Machine learning for medical image analysis is a well-established technique, and applying AI to existing imaging technologies represents a predictable improvement in diagnostic capabilities
Source Patent Element
Functional imaging system for lesion region analysis
PTD Variation
Incorporating IoT-enabled data transmission and cloud-based analytics platform
Obviousness Reasoning
Remote data transmission and cloud-based processing are standard techniques in medical technology, offering predictable benefits of enhanced data sharing and collaborative analysis
Source Patent Element
Functional image optimization using matrix processing techniques
PTD Variation
Blockchain-based secure data storage and personalized risk assessment
Obviousness Reasoning
Secure data management and personalized medical risk assessment are known approaches in healthcare informatics, representing a logical extension of existing diagnostic technologies
Source Patent Element
Voxel-based functional imaging of lesion regions
PTD Variation
Wearable DOT devices for continuous breast health monitoring
Obviousness Reasoning
Miniaturization and continuous monitoring are predictable technological progressions in medical diagnostic devices, utilizing standard engineering design principles
Source Patent Element
Functional image generation using DOT techniques
PTD Variation
Multi-modal integration of AI, IoT, and blockchain for comprehensive diagnostic system
Obviousness Reasoning
Combining multiple technological domains to enhance diagnostic capabilities is a standard approach in medical technology development, representing an obvious technological evolution
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857289 and the published technical disclosure, a person having ordinary skill in the art would find the integration of AI, IoT, and blockchain technologies with existing diffuse optical tomography imaging techniques to be an obvious and predictable extension of known medical diagnostic methodologies. The incremental technological combinations represent standard engineering approaches to enhancing medical imaging and diagnostic capabilities, thereby rendering potential patent claims in this domain obvious and non-patentable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,289
TitleSystems and methods of optimizing functional images of a lesion region using guided diffuse optical tomography
Assignee(s)Washington University